Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Using chirality to influence supramolecular gelation.

McAulay K, Dietrich B, Su H, Scott MT, Rogers S, Al-Hilaly YK, Cui H, Serpell LC, Seddon AM, Draper ER, Adams DJ.

Chem Sci. 2019 Jul 3;10(33):7801-7806. doi: 10.1039/c9sc02239b. eCollection 2019 Sep 7.

2.

Epigenetic Reprogramming and Emerging Epigenetic Therapies in CML.

Bugler J, Kinstrie R, Scott MT, Vetrie D.

Front Cell Dev Biol. 2019 Jul 17;7:136. doi: 10.3389/fcell.2019.00136. eCollection 2019. Review.

3.

Comparing thermal performance curves across traits: how consistent are they?

Kellermann V, Chown SL, Schou MF, Aitkenhead I, Janion-Scheepers C, Clemson A, Scott MT, Sgrò CM.

J Exp Biol. 2019 Jun 5;222(Pt 11). pii: jeb193433. doi: 10.1242/jeb.193433.

PMID:
31085593
4.

Platelet-rich plasma versus Tenex in the treatment of medial and lateral epicondylitis.

Boden AL, Scott MT, Dalwadi PP, Mautner K, Mason RA, Gottschalk MB.

J Shoulder Elbow Surg. 2019 Jan;28(1):112-119. doi: 10.1016/j.jse.2018.08.032.

PMID:
30551782
5.

Targeting quiescent leukemic stem cells using second generation autophagy inhibitors.

Baquero P, Dawson A, Mukhopadhyay A, Kuntz EM, Mitchell R, Olivares O, Ianniciello A, Scott MT, Dunn K, Nicastri MC, Winkler JD, Michie AM, Ryan KM, Halsey C, Gottlieb E, Keaney EP, Murphy LO, Amaravadi RK, Holyoake TL, Helgason GV.

Leukemia. 2019 Apr;33(4):981-994. doi: 10.1038/s41375-018-0252-4. Epub 2018 Sep 5.

6.

hsa-mir183/EGR1-mediated regulation of E2F1 is required for CML stem/progenitor cell survival.

Pellicano F, Park L, Hopcroft LEM, Shah MM, Jackson L, Scott MT, Clarke CJ, Sinclair A, Abraham SA, Hair A, Helgason GV, Aspinall-O'Dea M, Bhatia R, Leone G, Kranc KR, Whetton AD, Holyoake TL.

Blood. 2018 Apr 5;131(14):1532-1544. doi: 10.1182/blood-2017-05-783845. Epub 2018 Feb 5.

7.

Differences Between Relative and Absolute Speed and Metabolic Thresholds in Rugby League.

Scott TJ, Thornton HR, Scott MTU, Dascombe BJ, Duthie GM.

Int J Sports Physiol Perform. 2018 Mar 1;13(3):298-304. doi: 10.1123/ijspp.2016-0645. Epub 2018 Mar 1.

PMID:
28657854
8.

Epigenetic Reprogramming Sensitizes CML Stem Cells to Combined EZH2 and Tyrosine Kinase Inhibition.

Scott MT, Korfi K, Saffrey P, Hopcroft LE, Kinstrie R, Pellicano F, Guenther C, Gallipoli P, Cruz M, Dunn K, Jorgensen HG, Cassels JE, Hamilton A, Crossan A, Sinclair A, Holyoake TL, Vetrie D.

Cancer Discov. 2016 Nov;6(11):1248-1257. Epub 2016 Sep 14.

9.

Reducing Anesthesia and Health Care Cost Through Utilization of Child Life Specialists in Pediatric Radiation Oncology.

Scott MT, Todd KE, Oakley H, Bradley JA, Rotondo RL, Morris CG, Klein S, Mendenhall NP, Indelicato DJ.

Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):401-405. doi: 10.1016/j.ijrobp.2016.06.001. Epub 2016 Jun 5.

PMID:
27475669
10.

Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells.

Abraham SA, Hopcroft LE, Carrick E, Drotar ME, Dunn K, Williamson AJ, Korfi K, Baquero P, Park LE, Scott MT, Pellicano F, Pierce A, Copland M, Nourse C, Grimmond SM, Vetrie D, Whetton AD, Holyoake TL.

Nature. 2016 Jun 16;534(7607):341-6. doi: 10.1038/nature18288. Epub 2016 Jun 8.

11.

Fear potentiated startle increases phospholipase D (PLD) expression/activity and PLD-linked metabotropic glutamate receptor mediated post-tetanic potentiation in rat amygdala.

Krishnan B, Scott MT, Pollandt S, Schroeder B, Kurosky A, Shinnick-Gallagher P.

Neurobiol Learn Mem. 2016 Feb;128:65-79. doi: 10.1016/j.nlm.2015.12.009. Epub 2015 Dec 31.

12.

The Validity and Reliability of Global Positioning Systems in Team Sport: A Brief Review.

Scott MT, Scott TJ, Kelly VG.

J Strength Cond Res. 2016 May;30(5):1470-90. doi: 10.1519/JSC.0000000000001221. Review.

PMID:
26439776
13.

Antibody-based detection of protein phosphorylation status to track the efficacy of novel therapies using nanogram protein quantities from stem cells and cell lines.

Aspinall-O'Dea M, Pierce A, Pellicano F, Williamson AJ, Scott MT, Walker MJ, Holyoake TL, Whetton AD.

Nat Protoc. 2015 Jan;10(1):149-68. doi: 10.1038/nprot.2015.007. Epub 2014 Dec 18.

PMID:
25521791
14.

Fully automated high-throughput chromatin immunoprecipitation for ChIP-seq: identifying ChIP-quality p300 monoclonal antibodies.

Gasper WC, Marinov GK, Pauli-Behn F, Scott MT, Newberry K, DeSalvo G, Ou S, Myers RM, Vielmetter J, Wold BJ.

Sci Rep. 2014 Jun 12;4:5152. doi: 10.1038/srep05152.

15.

The antiproliferative activity of kinase inhibitors in chronic myeloid leukemia cells is mediated by FOXO transcription factors.

Pellicano F, Scott MT, Helgason GV, Hopcroft LE, Allan EK, Aspinall-O'Dea M, Copland M, Pierce A, Huntly BJ, Whetton AD, Holyoake TL.

Stem Cells. 2014 Sep;32(9):2324-37. doi: 10.1002/stem.1748.

16.

Radiation therapy for hemangioendothelioma: the university of Florida experience.

Scott MT, Indelicato DJ, Morris CG, Gibbs CP Jr, Scarborough MT, Reith JD, Marcus RB Jr, Zlotecki R, Mendenhall WM.

Am J Clin Oncol. 2014 Aug;37(4):360-3. doi: 10.1097/COC.0b013e31827a7cde.

PMID:
23275275
17.

Radiation therapy for angiosarcoma: the 35-year University of Florida experience.

Scott MT, Portnow LH, Morris CG, Marcus RB Jr, Mendenhall NP, Mendenhall WM, Indelicato DJ.

Am J Clin Oncol. 2013 Apr;36(2):174-80. doi: 10.1097/COC.0b013e3182436ea3.

PMID:
22314000
18.

Metabolism of [(14)c]chlorantraniliprole in the lactating goat.

Gaddamidi V, Scott MT, Swain RS, Macpherson D, Lowrie C.

J Agric Food Chem. 2011 Feb 23;59(4):1316-23. doi: 10.1021/jf103558n. Epub 2011 Jan 11.

PMID:
21222458
19.

Akt/PKB suppresses DNA damage processing and checkpoint activation in late G2.

Xu N, Hegarat N, Black EJ, Scott MT, Hochegger H, Gillespie DA.

J Cell Biol. 2010 Aug 9;190(3):297-305. doi: 10.1083/jcb.201003004. Epub 2010 Aug 2.

20.

Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation by de-repression of Chk1 catalytic activity.

Walker M, Black EJ, Oehler V, Gillespie DA, Scott MT.

Oncogene. 2009 Jun 18;28(24):2314-23. doi: 10.1038/onc.2009.102. Epub 2009 May 4.

21.

Vertebral artery reconstruction using microanastomosis and intraoperative neuromonitoring: a case report from Santiago, Chile.

Scott MT, Roper M, Mura J.

Am J Electroneurodiagnostic Technol. 2008 Jun;48(2):79-92.

PMID:
18680896
22.

The MDM2 ubiquitination signal in the DNA-binding domain of p53 forms a docking site for calcium calmodulin kinase superfamily members.

Craig AL, Chrystal JA, Fraser JA, Sphyris N, Lin Y, Harrison BJ, Scott MT, Dornreiter I, Hupp TR.

Mol Cell Biol. 2007 May;27(9):3542-55. Epub 2007 Mar 5.

23.

Chk1 is required for spindle checkpoint function.

Zachos G, Black EJ, Walker M, Scott MT, Vagnarelli P, Earnshaw WC, Gillespie DA.

Dev Cell. 2007 Feb;12(2):247-60.

24.

Internuclear synapse in the amygdala is not facilitated in fear conditioning.

Scott MT, Shinnick-Gallagher P.

Synapse. 2005 Jan;55(1):67-70.

PMID:
15515005
25.
26.
27.

Survival estimates for adults with cystic fibrosis born in the United Kingdom between 1947 and 1967. The UK Cystic Fibrosis Survey Management Committee.

Lewis PA, Morison S, Dodge JA, Geddes D, Coles EC, Russell G, Littlewood JM, Scott MT.

Thorax. 1999 May;54(5):420-2.

28.

Height and weight in cystic fibrosis: a cross sectional study. UK Cystic Fibrosis Survey Management Committee.

Morison S, Dodge JA, Cole TJ, Lewis PA, Coles EC, Geddes D, Russell G, Littlewood JM, Scott MT.

Arch Dis Child. 1997 Dec;77(6):497-500.

29.

Incidence, population, and survival of cystic fibrosis in the UK, 1968-95. UK Cystic Fibrosis Survey Management Committee.

Dodge JA, Morison S, Lewis PA, Coles EC, Geddes D, Russell G, Littlewood JM, Scott MT.

Arch Dis Child. 1997 Dec;77(6):493-6.

30.

Cystic fibrosis: the breakthrough to gene therapy.

Scott MT.

Prof Care Mother Child. 1994 Aug-Sep;4(6):164-5. No abstract available.

PMID:
8680183
31.

Application of microcolumn liquid chromatography-continuous-flow fast atom bombardment mass spectrometry in environmental studies of sulfonylurea herbicides.

Reiser RW, Barefoot AC, Dietrich RF, Fogiel AJ, Johnson WR, Scott MT.

J Chromatogr. 1991 Aug 21;554(1-2):91-101.

PMID:
1795041
32.

Suppressive substance produced by T cells from mice chronically infected with Trypanosoma cruzi. II. Partial biochemical characterization.

Liew FY, Schmidt JA, Liu DS, Millott SM, Scott MT, Dhaliwal JS, Croft SL.

J Immunol. 1988 Feb 1;140(3):969-73.

PMID:
3123553
34.

Effects of experimental acute pancreatitis in dogs on metabolism of lung surfactant phosphatidylcholine.

Das SK, Scott MT, McCuiston S.

Biochem Biophys Res Commun. 1987 May 29;145(1):612-8.

PMID:
3036136
35.

Impact of the 1986 Tax Reform Act on tax-exempt organizations' employee benefits plans.

O'Brien JP, Meadors GM, Scott MT, Mancino DM.

Health Law Vigil. 1986 Dec 19;9(25):6-10. No abstract available.

PMID:
10279710
36.

Adjuvant activity of saponin: antigen localization studies.

Scott MT, Goss-Sampson M, Bomford R.

Int Arch Allergy Appl Immunol. 1985;77(4):409-12.

PMID:
4018882
37.

Immunization of marmosets with Trypanosoma cruzi cell surface glycoprotein (GP90).

Scott MT, Neal RA, Woods NC.

Trans R Soc Trop Med Hyg. 1985;79(4):451-4.

PMID:
3936239
38.

The vaccine potential of cell surface glycoproteins from Trypanosoma cruzi.

Scott MT, Neal RA.

Philos Trans R Soc Lond B Biol Sci. 1984 Nov 13;307(1131):63-72.

PMID:
6151689
39.
40.
41.

In vitro dehalogenation of para-substituted aromatic halides in rat liver preparations.

Scott MT, Sinsheimer JE.

J Pharm Sci. 1984 Aug;73(8):1101-4.

PMID:
6387082
42.

Adjuvant requirements for protective immunization of mice using a Trypanosoma cruzi 90K cell surface glycoprotein.

Scott MT, Bahr G, Moddaber F, Afchain D, Chedid L.

Int Arch Allergy Appl Immunol. 1984;74(4):373-7.

PMID:
6429057
43.

A monoclonal antibody with specificity for Trypanosoma cruzi, central and peripheral neurones and glia.

Snary D, Flint JE, Wood JN, Scott MT, Chapman MD, Dodd J, Jessell TM, Miles MA.

Clin Exp Immunol. 1983 Dec;54(3):617-24.

45.

Tumour-induced specific suppression: a limitation to immunotherapy.

Scott MT.

Immunol Today. 1982 Jan;3(1):8-9. doi: 10.1016/0167-5699(82)90116-5. No abstract available.

PMID:
25290871
47.
49.
50.

Protective immunisation of mice using cell surface glycoprotein from Trypanosoma cruzi.

Scott MT, Snary D.

Nature. 1979 Nov 1;282(5734):73-4. No abstract available.

PMID:
116128

Supplemental Content

Loading ...
Support Center